These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 406803)

  • 1. The menace of mass screening.
    Bergman AB
    Am J Public Health; 1977 Jul; 67(7):601-2. PubMed ID: 406803
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanoma screening: focusing the public health journey.
    Koh HK
    Arch Dermatol; 2007 Jan; 143(1):101-3. PubMed ID: 17224549
    [No Abstract]   [Full Text] [Related]  

  • 3. Mammography utilization, public health impact, and cost-effectiveness in the United States.
    White E; Urban N; Taylor V
    Annu Rev Public Health; 1993; 14():605-33. PubMed ID: 8323604
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for AIDS: efficacy, cost, and consequences.
    Gostin L
    AIDS Public Policy J; 1987; 2(4):14-24. PubMed ID: 11650007
    [No Abstract]   [Full Text] [Related]  

  • 5. US licenses blood test for AIDS.
    Joyce C; Anderson I
    New Sci; 1985 Mar; 105(1446):3-4. PubMed ID: 11655676
    [No Abstract]   [Full Text] [Related]  

  • 6. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy.
    Bell R
    BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward a system of cancer screening in the United States: trends and opportunities.
    Breen N; Meissner HI
    Annu Rev Public Health; 2005; 26():561-82. PubMed ID: 15760301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead poisoning: from screening to primary prevention.
    Gellert GA; Wagner GA; Maxwell RM; Moore D; Foster L
    Pediatrics; 1994 Feb; 93(2):343-4. PubMed ID: 8121754
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass screening: is it cost-effective?
    Clayman CB
    JAMA; 1980 May 23-30; 243(20):2067-8. PubMed ID: 6768906
    [No Abstract]   [Full Text] [Related]  

  • 11. Mandatory AIDS testing: the legal, ethical and practical issues.
    Werdel AA
    Notre Dame J Law Ethics Public Policy; 1990; 5(1):155-221. PubMed ID: 11650435
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood lead in Canadian children: a current perspective.
    Godolphin W; Schmitt N; Anderson TW
    CMAJ; 1993 Feb; 148(4):517-9. PubMed ID: 8381702
    [No Abstract]   [Full Text] [Related]  

  • 13. Partner notification and HIV infections: misconceptions and recommendations.
    Dimas JT; Richland JH
    AIDS Public Policy J; 1989; 4(4):206-11. PubMed ID: 11650317
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost effectiveness of universal diabetes screening.
    Manag Care Interface; 2004 Oct; 17(10):59-60. PubMed ID: 15535080
    [No Abstract]   [Full Text] [Related]  

  • 15. The harms of screening: new attention to an old concern.
    Woolf SH; Harris R
    JAMA; 2012 Feb; 307(6):565-6. PubMed ID: 22318274
    [No Abstract]   [Full Text] [Related]  

  • 16. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism, pace of introducing AFP screening sparks debate.
    Klug J
    Ob Gyn News; 1980 Sep; 15(18):1+. PubMed ID: 11662825
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of screening for HIV.
    Thrasher AD; Ford CL; Nearing KA
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15906435
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and screening procedures for lead poisoning.
    Lin-Fu JS
    Pediatrics; 1971 Sep; 48(3):488-9. PubMed ID: 5094354
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of screening for latent tuberculosis infection.
    Taylor Z
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S127-33. PubMed ID: 11144542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.